BRPI0413206A - mutante de fsh por glicosilação - Google Patents

mutante de fsh por glicosilação

Info

Publication number
BRPI0413206A
BRPI0413206A BRPI0413206-8A BRPI0413206A BRPI0413206A BR PI0413206 A BRPI0413206 A BR PI0413206A BR PI0413206 A BRPI0413206 A BR PI0413206A BR PI0413206 A BRPI0413206 A BR PI0413206A
Authority
BR
Brazil
Prior art keywords
glycosylation
fsh
fsh mutant
mutant
lifes
Prior art date
Application number
BRPI0413206-8A
Other languages
English (en)
Inventor
Louise M Garone
Stephen J Arkinstall
William H Brondyk
Robert K Campbell
Xuliang Jiang
Sean D Mckenna
Mark Tepper
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of BRPI0413206A publication Critical patent/BRPI0413206A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"MUTANTE DE FSH POR GLICOSILAçãO". A presente invenção refere-se a um novo mutante de FSH com aumento de glicosilação e meias-vidas mais longas para uso na indução de foliculogênese em pacientes humanos. O mutante de FSH permite o uso de doses cumulativas menores de FSH para obter o mesmo ou melhor resultado clínico.
BRPI0413206-8A 2003-09-02 2004-09-02 mutante de fsh por glicosilação BRPI0413206A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49980203P 2003-09-02 2003-09-02
PCT/US2004/029042 WO2005020934A2 (en) 2003-09-02 2004-09-02 Fsh glycosylation mutant

Publications (1)

Publication Number Publication Date
BRPI0413206A true BRPI0413206A (pt) 2006-10-03

Family

ID=34272871

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413206-8A BRPI0413206A (pt) 2003-09-02 2004-09-02 mutante de fsh por glicosilação

Country Status (24)

Country Link
US (1) US7700112B2 (pt)
EP (1) EP1694271B1 (pt)
JP (1) JP4653090B2 (pt)
KR (1) KR101099809B1 (pt)
CN (1) CN1984926B (pt)
AT (1) ATE511829T1 (pt)
AU (1) AU2004268683B2 (pt)
BR (1) BRPI0413206A (pt)
CA (1) CA2535522A1 (pt)
CY (1) CY1112439T1 (pt)
DK (1) DK1694271T3 (pt)
EA (1) EA012175B1 (pt)
ES (1) ES2367784T3 (pt)
HK (1) HK1101315A1 (pt)
HR (1) HRP20110430T1 (pt)
IL (1) IL174037A0 (pt)
MX (1) MXPA06002119A (pt)
NO (1) NO20061446L (pt)
PL (1) PL1694271T3 (pt)
PT (1) PT1694271E (pt)
SI (1) SI1694271T1 (pt)
UA (1) UA88879C2 (pt)
WO (1) WO2005020934A2 (pt)
ZA (1) ZA200601803B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080219952A1 (en) 2005-08-26 2008-09-11 Ares Trading S.A. Process For the Preparation of Glycosylated Interferon Beta
EP1960419B1 (en) * 2005-12-09 2016-03-16 Ares Trading S.A. Method for purifying fsh or a fsh mutant
EA013975B1 (ru) 2005-12-22 2010-08-30 Мерк Сероно С.А. Мутантный fsh и способы его применения
AU2007207697B2 (en) 2006-01-17 2012-01-19 Merck Serono Sa Novel FSH glycosylation variant D3N
DK2125899T3 (da) * 2007-03-26 2013-02-11 Novartis Ag Biomarkører til forudsigelse af renal sikkerhed samt biomarkørsignaturer til overvågning af nyrefunktion
AR081755A1 (es) 2010-04-02 2012-10-17 Hanmi Holdings Co Ltd Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
CN108676096B (zh) * 2018-05-22 2022-03-29 北京伟杰信生物科技有限公司 重组猪fsh-ctp融合蛋白及其制备方法与应用
CA3160345A1 (en) * 2019-11-06 2021-05-14 The Regents Of The University Of Colorado, A Body Corporate Modified follicle-stimulating hormone and methods of using the same

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840896A (en) * 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
US4923805A (en) * 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
US5156957A (en) * 1983-11-02 1992-10-20 Genzyme Corporation Follicle stimulating hormone
US5639639A (en) * 1983-11-02 1997-06-17 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US4589402A (en) * 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
JP3045539B2 (ja) * 1989-02-21 2000-05-29 ワシントン ユニバーシティ 改変型生殖ホルモン
US5338835A (en) * 1989-02-21 1994-08-16 Washington University CTP-extended form of FSH
US5508261A (en) * 1991-06-18 1996-04-16 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
US6407205B1 (en) * 1997-06-04 2002-06-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College FSH-releasing peptides
ES2247710T3 (es) * 1997-06-20 2006-03-01 Akzo Nobel N.V. Antagonista de gonadotropina.
ATE329911T1 (de) * 1998-08-07 2006-07-15 Applied Research Systems Fsh mimetika zur behandlung von infertilität
PT1250148E (pt) * 2000-01-27 2004-09-30 Applied Research Systems Uso de fsh para o tratamento da infertilidade
US20020127652A1 (en) * 2000-02-11 2002-09-12 Schambye Hans Thalsgard Follicle stimulating hormones
WO2001058493A1 (en) * 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones
EP1487479B1 (en) * 2001-10-22 2012-06-20 Merck Serono SA Mutant glycoproteins

Also Published As

Publication number Publication date
UA88879C2 (en) 2009-12-10
WO2005020934A3 (en) 2007-02-15
MXPA06002119A (es) 2006-05-31
KR20070029620A (ko) 2007-03-14
CN1984926A (zh) 2007-06-20
EP1694271A2 (en) 2006-08-30
PL1694271T3 (pl) 2011-11-30
IL174037A0 (en) 2006-08-01
WO2005020934A2 (en) 2005-03-10
KR101099809B1 (ko) 2011-12-27
CN1984926B (zh) 2012-04-11
EA200600526A1 (ru) 2007-04-27
US7700112B2 (en) 2010-04-20
ES2367784T3 (es) 2011-11-08
AU2004268683A2 (en) 2005-03-10
DK1694271T3 (da) 2011-09-12
ZA200601803B (en) 2007-05-30
PT1694271E (pt) 2011-07-07
EP1694271B1 (en) 2011-06-08
AU2004268683B2 (en) 2010-06-24
ATE511829T1 (de) 2011-06-15
SI1694271T1 (sl) 2011-08-31
US20050100989A1 (en) 2005-05-12
CY1112439T1 (el) 2015-12-09
NO20061446L (no) 2006-03-30
HK1101315A1 (en) 2007-10-12
CA2535522A1 (en) 2005-03-10
AU2004268683A1 (en) 2005-03-10
JP2007508245A (ja) 2007-04-05
EA012175B1 (ru) 2009-08-28
HRP20110430T1 (hr) 2011-07-31
JP4653090B2 (ja) 2011-03-16

Similar Documents

Publication Publication Date Title
CY1112439T1 (el) Μεταλλαγμα fsh-γλυκοζυλιωσης
AU2003272536A8 (en) Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
AU2003264282A1 (en) Phenethanolamine derivatives and their use in the treatment of respiratory diseases
ATE312635T1 (de) Ventilanordnung
ATE323479T1 (de) Zusammensetzung für die verhinderung der glattmuskelkrankheiten, die ascorbat, arginin und magnesium enthält
DE60205067D1 (de) Einfach an jeden Zahnarztstuhl und/oder Operationstisch anpassbare Armstütze
BR0215404A (pt) processo e dispositivo para reduzir dosagem terapêutica
EP1536834A4 (en) DESIGN OF CHEMOKINE ANALOGS FOR THE TREATMENT OF HUMAN DISEASES
HUP9900681A2 (hu) TH1/TH2-citokinexpresszió modulálása Ribavirinnel és Ribavirin-analógokkal, aktivált T-limfocitákban
SE0102831D0 (sv) Anordning vid en handprotes
DE50101034D1 (de) Medizinischer oder dentalmedizinischer behandlungsstuhl
MXPA05001885A (es) El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of ***e dependency
WO2002076313A8 (fr) Extenseur de l'os maxillaire
MX2008008322A (es) Mutantes de fsh.
WO2004050679A3 (en) Mutant glycoproteins
AU2003281257A8 (en) A novel use of rapamycin and structural analogues thereof
AU2002364889A8 (en) Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
DE60304678D1 (de) Idraparinux (sanorg 34006) zur behandlung und sekundärprophylaxe von thromboembolien bei patienten mit tiefer venenthrombose
ATE95995T1 (de) Ergonomisches kopfkissen, insbesondere zur verhuetung und/oder behandlung von nackenbeschwerden.
BR8000814U (pt) Instrumento de massagem à vácuo
GR990100106A (el) Οργανο παθητικης κινησιοθεραπειας σε ορθια θεση για ατομα με αναπηρια στα κατω ακρα
FR2846551B1 (fr) Dispositif d'hydrotherapie destine au massage du corps humain
SE9704451D0 (sv) New method and compositions for the treatment of autoimmune diseases
TW519919U (en) Structure of health care chair capable of performing therapeutic ch'I-gong with biological spectrum

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: LABORATOIRES SERONO S.A. (CH)

Free format text: TRANSFERIDO DE: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: MERCK SERONO S.A. (CH)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2269 DE 01/07/2014.